These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 11978846)
41. Neuroprotective action of flavopiridol, a cyclin-dependent kinase inhibitor, in colchicine-induced apoptosis. Jorda EG; Verdaguer E; Canudas AM; Jiménez A; Bruna A; Caelles C; Bravo R; Escubedo E; Pubill D; Camarasa J; Pallàs M; Camins A Neuropharmacology; 2003 Oct; 45(5):672-83. PubMed ID: 12941380 [TBL] [Abstract][Full Text] [Related]
42. Cdk5 as a drug target for the treatment of Alzheimer's disease. Lau LF; Seymour PA; Sanner MA; Schachter JB J Mol Neurosci; 2002 Dec; 19(3):267-73. PubMed ID: 12540052 [TBL] [Abstract][Full Text] [Related]
43. CDK5-mediated phosphorylation of p19INK4d avoids DNA damage-induced neurodegeneration in mouse hippocampus and prevents loss of cognitive functions. Ogara MF; Belluscio LM; de la Fuente V; Berardino BG; Sonzogni SV; Byk L; Marazita M; Cánepa ET Biochim Biophys Acta; 2014 Jul; 1843(7):1309-24. PubMed ID: 24703879 [TBL] [Abstract][Full Text] [Related]
44. Intracellular localization of cyclin-dependent kinase 5 (CDK5) in mouse neuron: CDK5 is located in both nucleus and cytoplasm. Ino H; Chiba T Brain Res; 1996 Sep; 732(1-2):179-85. PubMed ID: 8891282 [TBL] [Abstract][Full Text] [Related]
45. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells. Lee JH; Kim KT J Neurochem; 2004 Nov; 91(3):634-47. PubMed ID: 15485494 [TBL] [Abstract][Full Text] [Related]
46. Neuronal cyclin-dependent kinase 5 activity is critical for survival. Tanaka T; Veeranna ; Ohshima T; Rajan P; Amin ND; Cho A; Sreenath T; Pant HC; Brady RO; Kulkarni AB J Neurosci; 2001 Jan; 21(2):550-8. PubMed ID: 11160434 [TBL] [Abstract][Full Text] [Related]
47. Expression of Cdk5, p35, and Cdk5-associated kinase activity in the developing rat lens. Gao CY; Zakeri Z; Zhu Y; He H; Zelenka PS Dev Genet; 1997; 20(3):267-75. PubMed ID: 9216066 [TBL] [Abstract][Full Text] [Related]
48. N-acetylcysteine prevents beta-amyloid toxicity by a stimulatory effect on p35/cyclin-dependent kinase 5 activity in cultured cortical neurons. Hsiao YH; Chen PS; Yeh SH; Lin CH; Gean PW J Neurosci Res; 2008 Sep; 86(12):2685-95. PubMed ID: 18512759 [TBL] [Abstract][Full Text] [Related]
49. Trace eyeblink conditioning requires the hippocampus but not autophosphorylation of alphaCaMKII in mice. Ohno M; Tseng W; Silva AJ; Disterhoft JF Learn Mem; 2005; 12(3):211-5. PubMed ID: 15897256 [TBL] [Abstract][Full Text] [Related]
51. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice. Hallows JL; Chen K; DePinho RA; Vincent I J Neurosci; 2003 Nov; 23(33):10633-44. PubMed ID: 14627648 [TBL] [Abstract][Full Text] [Related]
52. Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity. Wilkaniec A; Gąssowska-Dobrowolska M; Strawski M; Adamczyk A; Czapski GA J Neuroinflammation; 2018 Jan; 15(1):1. PubMed ID: 29301548 [TBL] [Abstract][Full Text] [Related]
53. Molecular characterization of a neuronal-specific protein that stimulates the activity of Cdk5. Shetty KT; Kaech S; Link WT; Jaffe H; Flores CM; Wray S; Pant HC; Beushausen S J Neurochem; 1995 May; 64(5):1988-95. PubMed ID: 7536802 [TBL] [Abstract][Full Text] [Related]
55. Role of cyclin-dependent kinase 5 and its activator P35 in local axon and growth cone stabilization. Hahn CM; Kleinholz H; Koester MP; Grieser S; Thelen K; Pollerberg GE Neuroscience; 2005; 134(2):449-65. PubMed ID: 15964697 [TBL] [Abstract][Full Text] [Related]
57. Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. Li BS; Zhang L; Takahashi S; Ma W; Jaffe H; Kulkarni AB; Pant HC EMBO J; 2002 Feb; 21(3):324-33. PubMed ID: 11823425 [TBL] [Abstract][Full Text] [Related]
58. Increase in the expression of the neuronal cyclin-dependent protein kinase cdk-5 during differentiation of N2A neuroblastoma cells. Muñoz JP; Alvarez A; Maccioni RB Neuroreport; 2000 Aug; 11(12):2733-8. PubMed ID: 10976953 [TBL] [Abstract][Full Text] [Related]
59. Identification of ribosomal protein L34 as a novel Cdk5 inhibitor. Moorthamer M; Chaudhuri B Biochem Biophys Res Commun; 1999 Feb; 255(3):631-8. PubMed ID: 10049762 [TBL] [Abstract][Full Text] [Related]